OBJECTIVE: To investigate the effect of weight loss on GLUT 4 content of insulin sensitive tissues of obese mice. SUBJECTS: Mice were made obese by neonatal treatment with monosodium glutamate (MSG). In addition, one group of obese animals was submitted to a caloric restriction to promote 20% weight loss (MSG-L). Both groups were compared to age-matched control mice. MEASUREMENTS: Anthropometric data, glycaemia and insulinaemia were measured. The GLUT 4 protein was assessed by Western blotting analysis in white (WAT) and brown (BAT) adipose tissue, and skeletal (SM) and cardiac (CM) muscles. RESULTS: The MSG mice were very obese according to their morphometric analysis, showing moderate hyperglycaemia with severe hyperinsulinaemia, and reduced (P`0.001) glucose/insulin (G/I) ratio. The procedure for weight loss promoted a signi®cant (P`0.001) reduction of both glycaemic and insulinaemic levels, and an increase in G/I ratio. Compared to control animals, the GLUT 4 content in obese MSG mice, was decreased by 30% (P`0.05) in SM and CM, by 80% (P`0.001) in BAT and in different subcellular membrane fractions of WAT. On the other hand, transporter protein content was restored to normal levels in MSG-L animals. CONCLUSION: The reduced GLUT 4 content of insulin sensitive tissues from MSG-treated obese mice is recovered by a 20% loss in weight. This mechanism can be involved in the observed increase of insulin sensitivity.
Introduction
Obesity has always seen as serious condition associated with increased mortality and morbidity. Recently, resistance to insulin-stimulated glucose uptake with hyperinsulinaemia has been reported as the major factor involved in the etiology of obesitydependent morbidities. 1, 2 In the late 1980s, a family of membrane proteins involved in glucose transport in mammalian cells was described, and one of the transporters, GLUT 4 isoform, is known to be only expressed in insulinsensitive tissues. 3±5 Several studies on altered glucose homeostasis have pointed out GLUT 4 as involved in the impaired glucose uptake, such as in NIDDM, 6±9 imposed hyperinsulinaemia, 10 as well as fasting and refeeding. 11±13 In obesity, the altered GLUT 4 expression is a controversial ®nding according to tissue (animal or human models) and the evolution of obesity, 14±17 and these discrepancies may be a consequence of the degree of insulin resistance. Ultimately, in two different models of hypothalamic obesity, aurothioglucose-and monosodium glutamate-treated mice, both severely insulin-resistant, a reduction on GLUT 4 content in all insulin-sensitive tissues was reported. 18 It is very well known that in obesity, loss of weight by caloric restriction leads to an increase in the insulin sensitivity.
19±21 Therefore, the purpose of this study was to determine whether or not the weight loss alters the GLUT 4 content of typical insulin sensitive tissues of obese monosodium glutamate-(MSG) treated mice.
Methods

Animals
Pregnant mice were housed singly prior to delivery. On days 1±5, the offspring were subcutaneously injected with either MSG (2 mg/g body weight) or 0.9% NaCl (control) daily. They were weaned at four weeks of age and then male mice were housed in groups of ®ve to seven under the same treatment. All animals were allowed free access to water and laboratory chow until the age of six months, when they were transferred to a special cage (28 6 18 6 11 cm, L 6 W 6 H respectively). This cage is provided with a grille, which divides the cage into two compartments allowing on one side, individual feeding and on the other, some animal contact through the grille. The animals were then housed two to a cage (same treatment). The MSG-treated mice were divided into two groups: one group (MSG) continued to have free access to food, as the control group, and the other group (MSG-L) started to receive only 3.5 g/d of the same laboratory chow (78% of the food intake of control and obese mice), to promote loss of weight. The animals were used for experiments four weeks later, when they were seven months old. The MSG-L animals had their food restriction schedule changed to free access to food, as the control and obese MSG mice, 72 h before being killed. Lee index [body weight (g) 1/3 /nasoanal length (cm)] was used to estimate the degree of obesity. 22 The experimental protocol was approved by the animal ethics committee of the Laboratory of Endocrinology, Institute of Biomedical Sciences, University of Sa Äo Paulo, Brazil.
Tissue and blood sampling
The mice were anaesthetized with sodium pentobarbital (50 mg/kg body weight, i.p.), blood samples were withdrawn from the inferior vena cava, and periepidydimal white adipose tissue (WAT) was removed and immediately homogenized for membrane preparation. Skeletal muscle (gastrocnemius), heart and interscapular brown adipose tissue (BAT) were also removed, weighed, frozen in liquid nitrogen, and stored at 770 C until assayed. All tissues, except the heart, were removed before respiratory arrest.
Membrane preparation
Cardiac and skeletal muscle from individual animals were homogenized in 7 vol of buffer (10 mM TrisHCl, 1 mM EDTA and 250 mM sucrose, pH 7.4). Homogenates were centrifuged at 1000 g for 10 min, the supernatant saved and the pellet resuspended in the same buffer and centrifuged again at 1000 g. The ®rst and second supernatants were combined and centrifuged at 150 000 g for 75 min. The ®nal pellet was resuspended in the same buffer and referred to as total membrane fraction (TM). Subcellular membrane fractions of WAT were prepared as previously described, 22 from pooled tissues of 4±6 animals. In short, the tissue was homogenized as described above, and centrifuged at 1000 g for 15 min. The fat cake was discarded and the infranatant, a fat-free extract (FFE), was centrifuged at 12 000 g for 15 min. The pellet, enriched in plasma membrane fragments, was resuspended as a plasma membrane (PM) fraction. The supernatant was subsequently centrifuged at 22 000 g for 15 min and 140 000 g for 75 min. The ®nal pellet, containing mainly low density microsomes, was resuspended as microsomal (M) fraction. BAT was treated as WAT to get FFE, but from individual tissue samples. All procedures were performed at 4 C.
Western blotting
A polyclonal anti-GLUT 4 antibody against the carboxy-terminal 12-amino acid peptide of rat GLUT 4 was raised in New Zealand rabbits. This antibody was developed in the Laboratory of Dr Masayuki Saito, Department of Biochemistry, Faculty of Veterinary Medicine, Hokkaido University, Japan, and was used for immunoblotting at 1X200 dilution. Equal amounts of membrane protein were solubilized in Laemmli's sample buffer, subjected to SDS-PAGE (10%) and electrophoretically transferred to nitrocellulose paper. After blocking with bovine serum albumin, the sheets were incubated with the anti-GLUT 4 antibody, with a subsequent washing and incubation with [ 
Results
Characteristics of animals
The general pro®le of the animals studied, is shown in Table 1 . The MSG-treated mice, which had free access to food until the age of seven months, were markedly obese. They had a signi®cant (P`0.001) increase in both Lee index and body weight. In the MSG-treated mice, fat tissue contents were three-and six-fold greater, respectively, for BAT and WAT. On the other hand, lean tissues, such as skeletal muscle and heart, were signi®cantly lighter than the control mice tissues. Hyperglycaemia was moderately, but signi®cantly, elevated (P`0.001), while hyperinsuli-naemia was severe, and the glucose/insulin (G/I) ratio was reduced (P`0.001), suggesting in vivo insulin resistance. Serum insulin levels in MSG mice were 2.5-fold higher (P`0.001) than the control value.
Food restriction in MSG-L mice promoted, as expected, a loss of 20% body weight. Both the Lee index and the tissue weight of WAT and BAT from MSG-L mice reduced signi®cantly (P`0.001). The heart and skeletal muscle weights did not change, remaining signi®cantly (P`0.01) lower than control mice tissues. The 20% weight loss reduced (P`0.001) the glycaemic and insulinaemic values, and increased (P`0.001) the G/I ratio to values similar to those observed in control mice, indicating an improvement in in vivo insulin sensitivity.
Abundance of GLUT 4 in insulin-sensitive tissues Figure 1 shows typical autoradiographies of GLUT 4 in insulin-sensitive tissues from control, MSG and MSG-L mice. In all tissues compared to controls, the blot density is lower in obese mice (MSG), and similar in (MSG-L) lean mice.
The quanti®cation of GLUT 4 in BAT, skeletal and cardiac muscle was performed in four different experiments for each tissue. Figure 2 shows the results expressed both by mg of protein ( Figure 2A ) and by whole tissue ( Figure 2B ). The GLUT 4 content in skeletal and cardiac muscle similarly decreased in MSG by approx 30% (P`0.05) when expressed per mg of protein, and by approx 40% when expressed per whole tissue. In BAT from obese mice (MSG), the GLUT 4 content decreased much more, by 80% (P b 0.001) either on a per mg protein or per whole tissue. The 20% weight loss restored the GLUT 4 content in all tissues. The effect of food restriction in BAT was very strong, as the tissue weight decreased by two-fold and the total GLUT 4 content simultaneously increased by ®ve-fold.
The GLUT 4 content in WAT is shown in Figure 3 . The periepidymal fat pad from 4±6 animals were pooled to perform a subcellular fractionation and ®ve different membrane preparations from each animal group, were analyzed on separate experiments. The GLUT 4 content, expressed by mg of membrane fraction protein, was reduced (P`0.05) in obese mice by approx 80%, both in FFE as well as in plasma membrane and microsome fractions. The loss of weight restored these GLUT 4 contents (Figure 3) . 
Discussion
With the euglycaemic insulin-clamp technique, many investigators have shown that tissue sensitivity to insulin declines by approx 30±40% when an individual becomes b 35±40% over ideal body weight. 1 This insulin resistance, with its compensatory hyperinsulinaemia and associated lipid abnormalities, is etiologically related to NIDDM, hypertension and atherosclerotic cardiovascular disease. Obesity-induced insulin resistance has been extensively studied in vitro, especially in adipose tissue. Cellular glucose transport, basal and maximally insulin-stimulated, is impaired in adipocytes from obese subjects. 23 which is the ®rst step for cellular glucose metabolism. In addition, it was reported in obese ad lib fed one-year-old rats that the responsiveness of WAT glucose metabolism to insulin, declines markedly and these changes can be completely reversed by underfeeding to achieve 21% loss in body weight. 19 Despite some controversial results obtained from different models of obesity, a reduction in the GLUT 4 content of insulin-sensitive tissues has been observed in obese MSG-treated mice. 18 However, it was reported that the insulin-induced GLUT 4 translocation is relatively preserved in these animals, 24 con®rming the role of total GLUT 4 reduction in altered glucose utilization of insulin resistance. As the reduced GLUT 4 content in insulin sensitive tissues of obese animals can have a leading role in the etiology of the insulin resistance, it is very important to observe that this phenomenon is reversible with loss of weight.
The caloric restriction imposed on the obese MSG mice promotes a 20% reduction (P`0.001) in their total body weight, which is expressed by a 60% and 45% reduction (P`0.001), respectively, in WAT and BAT tissue weight. This treatment was able to promote metabolic changes, signi®cantly reducing (P`0.001) both glycaemia and insulinaemia to similar values observed in control animals. According to Figure 2 The amount of GLUT 4 in brown adipose tissue (BAT), gastrocnemius (SM) and heart (CM) from control and monosodium glutamate-treated obese (MSG) and caloric-restricted (MSG-L) mice. Values are mean AE s.e.m. for four independent experiments, with different membrane preparation. In A, results were expressed by mg of membrane protein loaded in the electrophoresis; in B, results were expressed by whole tissue. * P`0.05 vs control and MSG-L. JF Caro, 25 the G/I ratio in humans, correlates with insulin sensitivity determined by the euglycaemic clamp, the minimal model technique, as well as the oral glucose tolerance test. Our data show that the loss of weight in obese animals increases their G/I ratio to values similar to those observed in control mice, con®rming an improvement in insulin sensitivity. The GLUT 4 analysis demonstrated that the weight loss of obese animals was accompanied by an increased (P`0.01) GLUT 4 content in all insulin sensitive tissues, and that may be related to the increased insulin sensitivity observed in these animals.
It is helpful to point out, as far as WAT GLUT 4 content is concerned, considering variables such as tissue weight and total protein recovery in each subcellular membrane fraction, several data can be obtained and they must be carefully analysed. As shown in Figure 3B , the total tissue PM GLUT 4 content decreased in MSG mice, compared to controls, despite the increased tissue weight and as a consequence of a very low protein recovery. By contrast, the weight loss diminished the periepididymal fat tissue weight, but increased the protein recovery, and thereafter the total tissue GLUT 4 content increased signi®cantly (P`0.05). Finally, the PM GLUT 4 content expressed by the unity of the cell surface area, showed a signi®cant (P`0.05) decrease in MSG mice, which disappears in MSG-L mice. These are very important physiological data, since they truly express the ability to transport glucose at the moment the tissue was removed.
The development of obesity-induced molecular and metabolic changes in insulin-sensitive tissues were elegantly demonstrated by Pe Ânicaud and co-workers 26, 27 in ventromedial hypothalamic obesity. Insulin resistance is preceded by a period of hypersensitivity to insulin with regard to whole-body glucose utilization, especially demonstrable in WAT. In addition, it was reported that the period of hyper-responsivity to insulin in WAT, is accompanied by increased expression of GLUT 4 and lipogenic enzymes, 28 as well as increased insulin receptor tyrosine kinase activity. 29 Similarly, increase in glucose utilization and GLUT 4 expression was reported to occur early in young genetically obese Zucker rats, before the establishment of insulin resistance. 30 A very important question is: what is the major regulatory factor involved in GLUT 4 expression? The insulin concentration was earlier proposed as a coordinately direct modulator of GLUT 4 expression, since the diabetic and fasted conditions reduce GLUT 4 content and insulin treatment, as well as refeeding, increases it. 10, 11 However, at present, it is well known that in hyperinsulinaemic obesity the GLUT 4 content is lower in tissues. In addition, we are demonstrating that the underfeeding treatment promotes a reduction of insulin concentration, accompanied by an increase of GLUT 4 content in insulin-sensitive tissues. Therefore, we can propose that modulation process changes according to the chronicity of the protocol, since the former models were developed in a short period, 24 h to one week, while underfeeding and MSG-induced obesity were developed in one and seven months, respectively.
In conclusion, the results clearly show that weight loss of obese mice promotes an increase of GLUT 4 content in all insulin-sensitive tissues. Certainly, this effect is involved in the well reported increase of insulin sensitivity observed as a consequence of weight loss. Furthermore, the GLUT 4 expression cannot always be directly correlated with serum insulin concentration.
